Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies림프성 악성종양 환자에서 BNT162b2 mRNA 백신 2회 및 3회 투여 후 항-SARS-CoV-2 항체 반응Article Published on 2022-06-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] affected anti-CD20 Anti-CD20 antibodies Anti-CD20 antibody anti-CD38 anti-RBD Anti-RBD IgG antibody antibody concentration Antibody concentrations Antibody Response B-cell malignancies B-cell malignancy benefit binding domain booster Cell Cohort Concentration conducted Course COVID-19 COVID-19 patient COVID-19 patients disorders dose effective evaluate haematological malignancies haematological malignancy Haematologicalmalignancies humoral Humoral response humoral responses IgG Immunocompromised increment IQR lymphoid lymphomas malignancies malignancy median monoclonal Mortality mRNA vaccination mRNA vaccine of BNT162b2 Patient patients patients treated plasma Plasma cell Prophylaxis quantification RBD SARS-CoV-2 Seroconversion seroconversion rate seroconverted serological serological response serology significantly spike the disease the vaccine therapy third dose Vaccine vaccine dose [DOI] 10.1016/j.cmi.2022.02.029 PMC 바로가기 [Article Type] Article
Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cellsExpiCHO 세포에서 SARS-CoV-2 스파이크 RBD의 발현, 정제 및 특성화Article Published on 2022-06-012022-09-11 Journal: Protein expression and purification [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody Antibody binding assay Antigen binding binding domain Blotting collection time Critical Culture culture medium Diagnosis diagnostic effective element ELISA test eukaryotic evaluate evaluated ExpiCHO cell ExpiCHO cells expressed Final flow cytometer functional good quality identify immune response Infection Interferometry Isolation mass mass spectrometry medium monomeric mutants Protein protein production protocol purification purified RBD Receptor binding domain receptor binding domain (RBD) robust SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 Spike RBD SARS-CoV-2 Spike. SDS-PAGE selective Spectrometry spike the RBD transiently transfected Vaccines virus western blotting [DOI] 10.1016/j.pep.2022.106071 PMC 바로가기 [Article Type] Article
Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?MOG 관련 장애와 SARS-CoV-2 감염 사이에 상관관계가 있습니까?Article Published on 2022-06-012022-09-12 Journal: European journal of neurology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% confidence interval age analysed anti-RBD anti-SARS-CoV-2 antibody association binding domain clinical presentation Control controls correlation COVID-19 COVID-19 pandemic determine diagnosed disorder drug ELISA assay First wave food glycoprotein IgG Immunoglobulin infections inflammatory disorder initial late phase MOG Myelitis non-specific not significant Odds ratio Optic neuritis pandemic Patient performed Preliminary data Presence RBD reported S1/S2 SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-COV-2 infection second wave serology Spike protein subject total Ig trimeric were used [DOI] 10.1111/ene.15304 PMC 바로가기 [Article Type] Article
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infectionSARS-CoV-2 감염 후 급성 심폐 증상에서 항체, 염증 표지자 및 심장초음파 소견의 역할Article Published on 2022-05-232022-09-11 Journal: JCI Insight [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, [키워드] Abnormalities age antibodies association baseline characteristics binding domain Biomarker Biomarkers breath C-reactive protein Cardiology Cardiopulmonary cardiovascular cardiovascular disease Cellular immune response chest pain COVID-19 cross-sectional analysis Dyspnea echocardiograms echocardiographic echocardiographic finding echocardiographic findings enrolled Evidence functional Hospitalization IgG antibody immune response individual Inflammation inflammatory markers investigation Logistic regression marker mechanism median median age occur palpitation palpitations parameter participant performed Receptor binding domain reported role SARS-COV-2 infection SARS-CoV-2 RBD SARS-CoV-2 receptor Sex Shortness of breath Symptom Symptoms systemic inflammation women [DOI] 10.1172/jci.insight.157053 PMC 바로가기 [Article Type] Article
Rapid biosensing SARS-CoV-2 antibodies in vaccinated healthy donors백신을 접종한 건강한 기증자의 신속한 바이오센싱 SARS-CoV-2 항체Article Published on 2022-05-152022-09-11 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] 3,3'-diaminobenzidine Analysis anti-RBD anti-S automated binding antibodies binding antibody binding domain Biolayer interferometry biosensors buffer can be used clinical clinical utility Cohort correlated COVID-19 COVID-19 vaccines domain enhancer enrolled Epidemiology fiber healthy healthy donor human serum immune response Inactivated Vaccines NAb NAbs Neutralizing antibodies neutralizing capacity participant protocol pseudovirus Randomly Rapid RBD Research Result SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 neutralizing antibodies SARS-CoV-2 neutralizing antibody sensitivity serum serum antibodies serum antibody speed Spike protein trials utility Vaccine variant [DOI] 10.1016/j.bios.2022.114054 PMC 바로가기 [Article Type] Article
Long-Term Comparison of 7 SARS-CoV-2 Antibody Assays in the North Zealand Covid-19 CohortNorth Zealand Covid-19 코호트에서 7개의 SARS-CoV-2 항체 분석의 장기 비교Article Published on 2022-05-042022-09-11 Journal: The journal of applied laboratory medicine [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody assay Antibody assays approved authorization automated binding domain clinical laboratory Cohort comparison study Consensus coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 detect diagnostic diagnostic sensitivity discrepancy ELISA assay ELISA assays Emergency Emergency use authorization immunoassay immunoassays implementation investigated Laboratory longitudinal study North pandemic PCR PCR-confirmed PCR-positive patient plateau platform raise reached remained respiratory Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2-positive individual sensitivities sensitivity Sensitivity and specificity Serological testing seronegative Seropositivity Siemens subpopulation Thermo Fisher Scientific [DOI] 10.1093/jalm/jfab173 PMC 바로가기 [Article Type] Article
Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2SARS-CoV-2에 대한 교차 반응성 점막 및 전신 항체 반응을 위한 열안정성 소단위 백신의 비강내 전달Article Published on 2022-05-032022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] ACE2 addition Against Alpha angiotensin angiotensin converting enzyme angiotensin converting enzyme 2 anti-RBD Anti-RBD antibody antibody Antibody Response Antibody responses Antibody titer Antibody titers approved Beta binding binding domain Breakthrough infection breakthrough infections chitosan circulation COVID-19 COVID-19 vaccines CpG cross-reactive delivery Delta variants domain Efficacy effort enzyme exclusion FIVE genetic material help Hesitancy IgA antibodies IgG1 IgG2a IL-12 Immunity immunization IMPROVE induce inhibited interleukin interleukin-12 intranasal intranasal vaccination intranasally isotype Laboratory mice mucosal mucosal immunity mutant oligonucleotide polypeptide Prevent PROTECT RBD RBD-specific antibodies RBD-specific antibody receptor Receptor binding domain receptor binding domain (RBD) reduce respiratory respiratory viruses response responses room temperature SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants specific antibodies stability subcutaneous vaccination subunit Subunit vaccine systemic temperature the vaccine thermostable upper respiratory tract vaccination Vaccine Vaccine development Vaccine hesitancy vaccine platform variants virus [DOI] 10.3389/fimmu.2022.858904 PMC 바로가기 [Article Type] Article
Designed SARS-CoV-2 receptor binding domain variants form stable monomers설계된 SARS-CoV-2 수용체 결합 도메인 변이체가 안정적인 단량체를 형성합니다.Article Published on 2022-05-012022-09-11 Journal: Biotechnology Journal [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제, [키워드] addressed aggregates antibody antibody assay validation Antigen antigen stability binding domain Cell convalescent sera COVID-19 COVID-19 patient cysteine cysteine residue Deletion enzyme enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays eukaryotic systems expression HEK293 homogeneous intrinsic maintenance mammalian cell mammalian cells monomer monomeric Neutralizing antibodies O-glycosylation site produced Protein RBD RBD variant Receptor binding Receptor binding domain Recombinant expression reduce SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 receptor SARS-CoV-2 spike SARS-CoV-2 test sequence serological shown Substitution the SARS-CoV-2 vaccine candidates Vaccine development variant virus-neutralizing antibodies virus-neutralizing antibody [DOI] 10.1002/biot.202100422 PMC 바로가기 [Article Type] Article
Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies고효율 요법으로 치료받는 다발성 경화증 환자에서 항-SARS-CoV-2 백신의 추가 용량 후 체액 반응Article Published on 2022-05-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Anti-RBD IgG anti-SARS-CoV-2 Anti-SARS-Cov2 vaccine antibody binding domain booster booster dose disease dose Efficacy evaluated Humoral response IgG management mRNA vaccine Multiple multiple sclerosis patients treated RBD receiving Result Seroconversion significant increase Therapies therapy third dose vaccination Vaccine [DOI] 10.1016/j.msard.2022.103776 PMC 바로가기 [Article Type] Article
Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis낭포성 섬유증이 있는 청소년 및 젊은 성인에서 COVID-19 BNT162b2 백신의 면역원성Article Published on 2022-05-012022-09-11 Journal: Journal of cystic fibrosis : official journal of t [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] AEs antibody association binding domain BNT162b2 BNT162b2 vaccine Control COVID-19 Cystic cystic fibrosis dose epidemiological fibrosis Genotype healthy control healthy controls immunogenic immunogenicity investigated Local median median age medications NAbs Neutralizing no significant difference no significant differences P-value parameters Patient patients phenotype Protein RBD reactogenicity SARS-CoV-2 SARS-CoV-2 BNT162b2 second dose severity Severity of disease systemic adverse event the disease U/mL Vaccine [DOI] 10.1016/j.jcf.2022.04.004 PMC 바로가기 [Article Type] Article